Ebola virus does not block apoptotic signaling pathways

Journal of Virology

Volumn 87, Issue 10, 2013, Pages 5384-5396

  Olejnik, Judith ^a,b,c   Schmidt, Kristina M ^a,b   Mühlberger, Elke ^a,b   Alonso, Jesus ^d   Patterson, Jean L ^d   Yan, Zhen ^e   Wang, Wei ^e   Marzi, Andrea ^f   Ebihara, Hideki ^f   Yang, Jinghua ^a   Ryabchikova, Elena ^g  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY   (United States)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

^d SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^e FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

^g INSTITUTE OF CHEMICAL BIOLOGY AND FUNDAMENTAL MEDICINE   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; DOUBLE STRANDED RNA; PROTEIN KINASE R;

APOPTOSIS; ARTICLE; CELL STIMULATION; CELL SURFACE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; EBOLA VIRUS; ENZYME ACTIVATION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA VIRUS INFECTION; UPREGULATION; VIRUS LOAD; VIRUS REPLICATION;

ANIMALS; CELL DEATH; CERCOPITHECUS AETHIOPS; EBOLAVIRUS; HELA CELLS; HUMANS; SIGNAL TRANSDUCTION; VERO CELLS;

EID: 84877343266     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01461-12     Document Type: Article

References (79)

1. Kuhn JH, Dodd LE, Wahl-Jensen V, Radoshitzky SR, Bavari S, Jahrling PB. 2011. Evaluation of perceived threat differences posed by filovirus variants. Biosecur. Bioterror. 9:361-371.
2. Olejnik J, Ryabchikova E, Corley RB, Mühlberger E. 2011. Intracellular events and cell fate in filovirus infection. Viruses 3:1501-1531.
3. Baize S, Leroy EM, Georges-Courbot MC, Capron M, Lansoud-Soukate J, Debré P, Fisher-Hoch SP, McCormick JB, Georges AJ. 1999. Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. Nat. Med. 5:423-426.
4. Baize S, Leroy EM, Georges AJ, Georges-Courbot MC, Capron M, Bedjabaga I, Lansoud-Soukate J, Mavoungou E. 2002. Inflammatory responses in Ebola virus-infected patients. Clin. Exp. Immunol. 128:163-168.
5. Baize S, Leroy EM, Mavoungou E, Fisher-Hoch SP. 2000. Apoptosis in fatal Ebola infection. Does the virus toll the bell for immune system? Apoptosis 5:5-7.
6. Bradfute SB, Braun DR, Shamblin JD, Geisbert JB, Paragas J, Garrison A, Hensley LE, Geisbert TW. 2007. Lymphocyte death in a mouse model of Ebola virus infection. J. Infect. Dis. 196(Suppl 2):S296 -S304. doi:10 .1086/520602.
7. Bradfute SB, Swanson PE, Smith MA, Watanabe E, McDunn JE, Hotchkiss RS, Bavari S. 2010. Mechanisms and consequences of ebolavirusinduced lymphocyte apoptosis. J. Immunol. 184:327-335.
8. Geisbert TW, Hensley LE, Gibb TR, Steele KE, Jaax NK, Jahrling PB. 2000. Apoptosis induced in vitro and in vivo during infection by Ebola and Marburg viruses. Lab. Invest. 80:171-186.
9. Geisbert TW, Hensley LE, Larsen T, Young HA, Reed DS, Geisbert JB, Scott DP, Kagan E, Jahrling PB, Davis KJ. 2003. Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. Am. J. Pathol. 163:2347-2370.
10. Gupta M, Spiropoulou C, Rollin PE. 2007. Ebola virus infection of human PBMCs causes massive death of macrophages, CD4 and CD8 T cell sub-populations in vitro. Virology 364:45-54.
11. Reed DS, Hensley LE, Geisbert JB, Jahrling PB, Geisbert TW. 2004. Depletion of peripheral blood T lymphocytes and NK cells during the course of Ebola hemorrhagic fever in cynomolgus macaques. Viral Immunol. 17:390-400.
12. Wauquier N, Becquart P, Padilla C, Baize S, Leroy EM. 2010. Human fatal Zaire Ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis. PLoS Negl. Trop. Dis. 4:e837. doi:10.1371/journal.pntd.0000837.
13. Hensley LE, Young HA, Jahrling PB, Geisbert TW. 2002. Proinflammatory response during Ebola virus infection of primate models: possible involvement of the tumor necrosis factor receptor superfamily. Immunol. Lett. 80:169 -179.
14. Leroy EM, Baize S, Debre P, Lansoud-Soukate J, Mavoungou E. 2001. Early immune responses accompanying human asymptomatic Ebola infections. Clin. Exp. Immunol. 124:453-460.
15. Rubins KH, Hensley LE, Wahl-Jensen V, Daddario DiCaprio KM, Young HA, Reed DS, Jahrling PB, Brown PO, Relman DA, Geisbert TW. 2007. The temporal program of peripheral blood gene expression in the response of nonhuman primates to Ebola hemorrhagic fever. Genome Biol. 8:R174. doi:10.1186/gb-2007-8-8-r174.
16. Gupta M, Goldsmith CS, Metcalfe MG, Spiropoulou CF, Rollin PE. 2010. Reduced virus replication, proinflammatory cytokine production, and delayed macrophage cell death in human PBMCs infected with the newly discovered Bundibugyo ebolavirus relative to Zaire ebolavirus. Virology 402:203-208.
17. Best SM. 2008. Viral subversion of apoptotic enzymes: escape from death row. Annu. Rev. Microbiol. 62:171-192.
18. Hotchkiss RS, Strasser A, McDunn JE, Swanson PE. 2009. Cell death. N. Engl. J. Med. 361:1570 -1583.
19. Duprez L, Wirawan E, Vanden Berghe T, Vandenabeele P. 2009. Major cell death pathways at a glance. Microbes Infect. 11:1050-1062.
20. Vanlangenakker N, Vanden Berghe T, Vandenabeele P. 2012. Many stimuli pull the necrotic trigger, an overview. Cell Death Differ. 19:75-86.
21. Galluzzi L, Maiuri MC, Vitale I, Zischka H, Castedo M, Zitvogel L, Kroemer G. 2007. Cell death modalities: classification and pathophysiological implications. Cell Death Differ. 14:1237-1243.
22. Loos B, Engelbrecht AM. 2009. Cell death: a dynamic response concept. Autophagy 5:590-603.
23. Degterev A, Boyce M, Yuan J. 2003. A decade of caspases. Oncogene 22:8543-8567.
24. Thorburn A. 2004. Death receptor-induced cell killing. Cell. Signal. 16: 139-144.
25. Wang S, El-Deiry WS. 2003. TRAIL and apoptosis induction by TNFfamily death receptors. Oncogene 22:8628-8633.
26. Burlacu A. 2003. Regulation of apoptosis by Bcl-2 family proteins. J. Cell. Mol. Med. 7:249-257.
27. Unterholzner L, Bowie AG. 2008. The interplay between viruses and innate immune signaling: recent insights and therapeutic opportunities. Biochem. Pharmacol. 75:589-602.
28. García MA, Meurs EF, Esteban M. 2007. The dsRNA protein kinase PKR: virus and cell control. Biochimie 89:799-811.
29. Gil J, Esteban M. 2000. Induction of apoptosis by the dsRNA-dependent protein kinase (PKR): mechanism of action. Apoptosis 5:107-114.
30. Pindel A, Sadler A. 2011. The role of protein kinase R in the interferon response. J. Interferon Cytokine Res. 31:59-70.
31. Gil J, García MA, Esteban M. 2002. Caspase 9 activation by the dsRNAdependent protein kinase, PKR: molecular mechanism and relevance. FEBS Lett. 529:249-255.
32. Ramanan P, Shabman RS, Brown CS, Amarasinghe GK, Basler CF, Leung DW. 2011. Filoviral immune evasion mechanisms. Viruses 3:1634-1649.
33. Fei Z, Liu Y, Yan Z, Fan D, Alexander A, Yang JH. 2011. Targeting viral dsRNA for antiviral prophylaxis. FASEB J. 25:1767-1774.
34. Ebihara H, Theriault S, Neumann G, Alimonti JB, Geisbert JB, Hensley LE, Groseth A, Jones SM, Geisbert TW, Kawaoka Y, Feldmann H. 2007.
35. Towner JS, Paragas J, Dover JE, Gupta M, Goldsmith CS, Huggins JW, Nichol ST. 2005. Generation of eGFP expressing recombinant Zaire ebolavirus for analysis of early pathogenesis events and high-throughput antiviral drug screening. Virology 332:20-27.
36. Bitzer M, Prinz F, Bauer M, Spiegel M, Neubert WJ, Gregor M, Schulze-Osthoff K, Lauer U. 1999. Sendai virus infection induces apoptosis through activation of caspase-8 (FLICE) and caspase-3 (CPP32). J. Virol. 73:702-708.
37. Gadaleta P, Vacotto M, Coulombié F. 2002. Vesicular stomatitis virus induces apoptosis at early stages in the viral cycle and does not depend on virus replication. Virus Res. 86:87-92.
38. Sordet O, Khan QA, Kohn KW, Pommier Y. 2003. Apoptosis induced by topoisomerase inhibitors. Curr. Med. Chem. Anticancer Agents 3:271-290.
39. Chaitanya GV, Steven AJ, Babu PP. 2010. PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration. Cell Commun. Signal. 8:31. doi:10.1186/1478-811X-8-31.
40. Gobeil S, Boucher CC, Nadeau D, Poirier GG. 2001. Characterization of the necrotic cleavage of poly(ADP-ribose) polymerase (PARP-1): implication of lysosomal proteases. Cell Death Differ. 8:588-594.
41. Feng Z, Cerveny M, Yan Z, He B. 2007. The VP35 protein of Ebola virus inhibits the antiviral effect mediated by double-stranded RNA-dependent protein kinase PKR. J. Virol. 81:182-192.
42. Schümann M, Gantke T, Mühlberger E. 2009. Ebola virus VP35 antagonizes PKR activity through its C-terminal interferon inhibitory domain. J. Virol. 83:8993-8997.
43. Strahle L, Garcin D, Kolakofsky D. 2006. Sendai virus defectiveinterfering genomes and the activation of interferon-beta. Virology 351: 101-111.
44. Gonzalvez F, Lawrence D, Yang B, Yee S, Pitti R, Marsters S, Pham VC, Stephan JP, Lill J, Ashkenazi A. 2012. TRAF2 sets a threshold for extrinsic apoptosis by tagging caspase-8 with a ubiquitin shutoff timer. Mol. Cell 48:888-899.
45. Tawa P, Hell K, Giroux A, Grimm E, Han Y, Nicholson DW, Xanthoudakis S. 2004. Catalytic activity of caspase-3 is required for its degradation: stabilization of the active complex by synthetic inhibitors. Cell Death Differ. 11:439-447.
46. Emeny JM, Morgan MJ. 1979. Regulation of the interferon system: evidence that Vero cells have a genetic defect in interferon production. J. Gen. Virol. 43:247-252.
47. Rider TH, Zook CE, Boettcher TL, Wick ST, Pancoast JS, Zusman BD. 2011. Broad-spectrum antiviral therapeutics. PLoS One 6:e22572. doi:10 .1371/journal.pone.0022572.
48. Chowdhury I, Tharakan B, Bhat GK. 2008. Caspases-an update. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 151:10-27.
49. Sordet O, Rébé C, Plenchette S, Zermati Y, Hermine O, Vainchenker W, Garrido C, Solary E, Dubrez-Daloz L. 2002. Specific involvement of caspases in the differentiation of monocytes into macrophages. Blood 100: 4446-4453.
50. Baskerville A, Bowen ET, Platt GS, McArdell LB, Simpson DI. 1978. The pathology of experimental Ebola virus infection in monkeys. J. Pathol. 125:131-138.
51. Ryabchikova E, Kolesnikova L, Smolina M, Tkachev V, Pereboeva L, Baranova S, Grazhdantseva A, Rassadkin Y. 1996. Ebola virus infection in guinea pigs: presumable role of granulomatous inflammation in pathogenesis. Arch. Virol. 141:909-921.
52. Ryabchikova E, Price BBS. 2004. Ebola and Marburg viruses: a view of infection using electron microscopy. Battelle Press, Columbus, OH.
53. Ryabchikova EI, Kolesnikova LV, Luchko SV. 1999. An analysis of features of pathogenesis in two animal models of Ebola virus infection. J. Infect. Dis.179(Suppl 1):S199-S202.doi:10.1086/514293 .
54. Kroemer G, Jäättelä M. 2005. Lysosomes and autophagy in cell death control. Nat. Rev. Cancer 5:886-897.
55. Schmidt KM, Schümann M, Olejnik J, Krähling V, Mühlberger E. 2011. Recombinant Marburg virus expressing EGFP allows rapid screening of virus growth and real-time visualization of virus spread. J. Infect. Dis. 204(Suppl 3):S861-S870. doi:10.1093/infdis/jir308.
56. Cho YS, Challa S, Moquin D, Genga R, Ray TD, Guildford M, Chan FK. 2009. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 137: 1112-1123.
57. Upton JW, Kaiser WJ, Mocarski ES. 2010. Virus inhibition of RIP3-dependent necrosis. Cell Host Microbe 7:302-313.
58. Kirshner JR, Karpova AY, Kops M, Howley PM. 2005. Identification of TRAIL as an interferon regulatory factor 3 transcriptional target. J. Virol. 79:9320-9324.
59. Baetu TM, Kwon H, Sharma S, Grandvaux N, Hiscott J. 2001. Disruption of NF-kappaB signaling reveals a novel role for NF-kappaB in the regulation of TNF-related apoptosis-inducing ligand expression. J. Immunol. 167:3164-3173.
60. Almasan A, Ashkenazi A. 2003. Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy. Cytokine Growth Factor Rev. 14:337-348.
61. Falschlehner C, Schaefer U, Walczak H. 2009. Following TRAIL's path in the immune system. Immunology 127:145-154.
62. Kotelkin A, Prikhod'ko EA, Cohen JI, Collins PL, Bukreyev A. 2003. Respiratory syncytial virus infection sensitizes cells to apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligand. J. Virol. 77: 9156-9172.
63. Zhu DM, Shi J, Liu S, Liu Y, Zheng D. 2011. HIV infection enhances TRAIL-induced cell death in macrophage by down-regulating decoy receptor expression and generation of reactive oxygen species. PLoS One 6:e18291. doi:10.1371/journal.pone.0018291.
64. Kimberlin CR, Bornholdt ZA, Li S, Woods VL, Jr, MacRae IJ, Saphire EO. 2010. Ebolavirus VP35 uses a bimodal strategy to bind dsRNA for innate immune suppression. Proc. Natl. Acad. Sci. U. S. A. 107:314-319.
65. Leung DW, Prins KC, Borek DM, Farahbakhsh M, Tufariello JM, Ramanan P, Nix JC, Helgeson LA, Otwinowski Z, Honzatko RB, Basler CF, Amarasinghe GK. 2010. Structural basis for dsRNA recognition and interferon antagonism by Ebola VP35. Nat. Struct. Mol. Biol. 17:165-172.
66. Hastie KM, Bale S, Kimberlin CR, Saphire EO. 2012. Hiding the evidence: two strategies for innate immune evasion by hemorrhagic fever viruses. Curr. Opin. Virol. 2:151-156.
67. Iordanov MS, Kirsch JD, Ryabinina OP, Wong J, Spitz PN, Korcheva VB, Thorburn A, Magun BE. 2005. Recruitment of TRADD, FADD, and caspase 8 to double-stranded RNA-triggered death inducing signaling complexes (dsRNA-DISCs). Apoptosis 10:167-176.
68. Iordanov MS, Ryabinina OP, Schneider P, Magun BE. 2005. Two mechanisms of caspase 9 processing in double-stranded RNA-and virustriggered apoptosis. Apoptosis 10:153-166.
69. Chattopadhyay S, Marques JT, Yamashita M, Peters KL, Smith K, Desai A, Williams BR, Sen GC. 2010. Viral apoptosis is induced by IRF-3-mediated activation of Bax. EMBO J. 29:1762-1773.
70. Heylbroeck C, Balachandran S, Servant MJ, DeLuca C, Barber GN, Lin R, Hiscott J. 2000. The IRF-3 transcription factor mediates Sendai virusinduced apoptosis. J. Virol. 74:3781-3792.
71. Estornes Y, Toscano F, Virard F, Jacquemin G, Pierrot A, Vanbervliet B, Bonnin M, Lalaoui N, Mercier-Gouy P, Pachéco Y, Salaun B, Renno T, Micheau O, Lebecque S. 2012. dsRNA induces apoptosis through an atypical death complex associating TLR3 to caspase-8. Cell Death Differ. 19:1482-1494.
72. Han KJ, Su X, Xu LG, Bin LH, Zhang J, Shu HB. 2004. Mechanisms of the TRIF-induced interferon-stimulated response element and NFkappaB activation and apoptosis pathways. J. Biol. Chem. 279:15652-15661.
73. Bosio CM, Aman MJ, Grogan C, Hogan R, Ruthel G, Negley D, Mohamadzadeh M, Bavari S, Schmaljohn A. 2003. Ebola and Marburg viruses replicate in monocyte-derived dendritic cells without inducing the production of cytokines and full maturation. J. Infect. Dis. 188:1630-1638.
74. Chang TH, Kubota T, Matsuoka M, Jones S, Bradfute SB, Bray M, Ozato K. 2009. Ebola Zaire virus blocks type I interferon production by exploiting the host SUMO modification machinery. PLoS Pathog. 5:e1000493. doi:10.1371/journal.ppat.1000493.
75. Jin H, Yan Z, Prabhakar BS, Feng Z, Ma Y, Verpooten D, Ganesh B, He B. 2010. The VP35 protein of Ebola virus impairs dendritic cell maturation induced by virus and lipopolysaccharide. J. Gen. Virol. 91:352-361.
76. Leung LW, Park MS, Martinez O, Valmas C, López CB, Basler CF. 2011. Ebolavirus VP35 suppresses IFN production from conventional but not plasmacytoid dendritic cells. Immunol. Cell Biol. 89:792-802.
77. Okumura A, Pitha PM, Yoshimura A, Harty RN. 2010. Interaction between Ebola virus glycoprotein and host Toll-like receptor 4 leads to induction of proinflammatory cytokines and SOCS1. J. Virol. 84:27-33.
78. Weber F, Wagner V, Rasmussen SB, Hartmann R, Paludan SR. 2006. Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. J. Virol. 80:5059-5064.
79. Takeuchi K, Komatsu T, Kitagawa Y, Sada K, Gotoh B. 2008. Sendai virus C protein plays a role in restricting PKR activation by limiting the generation of intracellular double-stranded RNA. J. Virol. 82:10102-10110.